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ABSTRACT  
 
Extracolonic manifestations of Familial Adenomatous Polyposis often associated 
with Gardner syndrome. We report a case of patient post panproctocolectomy 
with gastric and duodenal polyp found during upper GI scope. A rare condition 
which cause management dilemma as the patient asymptomatic. We review few 
literature regarding the latest recommendation on the management of 
extracolonic manifestation of FAP particularly gastric and duodenal polyposis in 
patient with FAP. Most expert agreed that duodenal polyposis should be manage 
based on Spigelman staging. For Stage 1 and Stage 2, recommended for 
surveillance. For Stage 3, require medical or endoscopic treatment while Stage 
4, surgical option should be considered in patient age more than 35 years old. 
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ÖZET 
 
Ailesel Adenomatöz Polipozun ekstrakolonik belirtileri Gardner sendromu ile 
ilişkilidir. Üst GI skopisi sırasında gastrik ve duodenal polip saptanan 
panproktokolektomi sonrası bir olguyu sunuyoruz. Asemptomatik hasta olarak 
yönetim ikilemine neden olan nadir bir durumdur. FAP'lı ve özellikle gastrik ve 
duodenal polipozlu hastada FAP’ın ekstrakolonik yönetimi hakkındaki en son 
önerilerle ilgili literatür gözden geçirilmiştir. Çoğu uzman, duodenal polipozun 
Spigelman evrelemesine dayanarak yönetilmesi gerektiği konusunda hemfikirdir. 
Evre 1 ve Evre 2 için, gözetim için önerilir. Evre 3 için, tıbbi veya endoskopik tedavi 
gerektirirken Evre 4, 35 yaşın üzerindeki hasta yaşlarında cerrahi seçenek 
düşünülmelidir. 
 
Anahtar Sözcükler: Ekstrakolonik FAP yaklaşımı, Gardner sendromu 
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INTRODUCTION 
 
Familial adenomatous polyposis (FAP) is an autosomal dominant inherited 
cancer-predisposition syndrome that is causally linked to the adenomatous 
polyposis coli (APC) gene located on chromosome 5q21 (1). Characterize by 
diffuse intestinal polyposis. The disease penetrance is up to 100% at the age of 
40 years old (2). Thus required prophylactic colectomy which has been a standard 
practice all around the world. However surgical intervention for those who has 
polyposis elsewhere still controversial in term of extend of surgery, as further 
resection may end up with morbidity. We present a case of FAP with extracolonic 
manifestation ( Gastric and Duodenal polyposis) which has been noted during 
follow up scope post prophylactic pan-proctocolectomy. We review few 
literature regarding the latest recommendation on the management of 
extracolonic manifestation of FAP particularly gastric and duodenal polyposis in 
patient with FAP. 
  
CASE REPORT 
  
Mr RI, a 49-years-old gentleman with strong family of FAP who presented with 
complained of altered bowel habit for almost 2 years. Further work up showed 
multiple polyps from caecum to rectum with invasive sigmoid cancer. 
Panproctocolectomy with ileoanal anastomosis was successfully performed and 
patient subsequently undergone chemotherapy.  
Post-operative follow up OGDS revealed multiple polyps within stomach and 
duodenum (Figure 1, Figure 2) which were biopsied and showed adenomatous 
polyps. However patient was not keen for any subsequent surgical intervention. 
 
 
 Figure 1: Multiple gastric polyp ( black arrow) 
 
 
 
 Figure 2: Small polyp on the duodenum. 
 
DISCUSSION 
 
Upper GI polyps (Gastric and duodenal adenoma) are present nearly 90% of 
FAP patient by the age of 70 years old with 12% discovered during upper scope 
(3). 2/3 of duodenal polyps occur in papilla or periampullary region, while 
incidence of gastric polyps estimated around 26%-61% in patient with FAP .(3) 
Incidence of FAP-associated gastric cancer in a large Korean series is 4.2%  while 
from a Japanese series is 2.1% which was much higher than the incidence 
reported from Western countries, 0.6% (4). 
Most expert agreed that duodenal polyposis should be manage based on 
Spigelman staging based on villous changes and severity of dysplasia (Table 1) 
(5,6). However Spigelman stage did not predict risk of ampullary cancer as it ony 
predict duodenal cancer(7). For Stage 1 and Stage 2, recommended for 
surveillance. For Stage 3, require medical or endoscopic treatment while Stage 
4, surgical option should be considered in patient age more than 35 years old (8). 
As for surveillance OGDS for duodenal polyposis in FAP patient, 
recommendations are; stage 0 every 5 years; stage I every 3-5 years; stage II 
every 3 years; stage III every 6–12 months with consideration for surgery. For 
stage IV recommended to consider duodenectomy (5,6,8)(Table 2). Surgical 
options include pylorus-preserving pancreaticoduodenectomy (PPPDR), 
pancreas-sparing duodenectomy, duodenotomy with surgical polypectomy, and 
ampullectomy (9).  Duodenotomy with polypectomy is the least preferred, as it 
has been associated with up to100% recurrence of adenomas within 6–36 
months (10). As for our case his Spigelman score was 5, he was planned for re 
scope in 3 years 
 
Table 1 Spigelman scoring system for duodenal adenomas 
 
 
Variables 1 point 2 points 3 points 
Number of polyps 1-4 5-20 >20 
Polyp size (mm) 1-4 5-10 >10 
Histology Tubular Tubulovillous Villous 
Dysplasia Mild Moderate Severe 
*The Spigelman score is calculated by adding the scores from each of 
the 4 categories (polyp number, polyp size, histology, and dysplasia), 
yielding a score ranging from 0-12 
 
Table 2 Recommendations based on Spigelman stage 
  
               
Spigelman 
score 
Spigelman 
stage 
Recommendation 
0 0 Re-scope in 5 years 
1-4 I Re-scope in 3-5 years 
5-6 II Re-scope in 3 years 
7-8 III Re-scope in 1 year 
9-12 IV Consider duodenectomy vs. 
re-scope in 6 months 
 
CONCLUSION  
  
This case emphasizes the importance of having the standardize guideline in 
treating rare case of Gardner Syndrome. It is important to highlight to the patient 
the need of surveillance scope even though patient was asymptomatic, as further 
treatment will be decided based on scope findings and its risk of malignant 
transformation. 
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